EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Susceptibility and Distribution Characteristics of Mycoplasma pneumoniae Isolates in Beijing, China, from 2017 to 2025

Chao Yan, Yujie Chen, An Su, Xuanfeng Liu, Xinyu Jia, Xue Ren, Hanqing Zhao, Yanling Feng, Jinghua Cui, Yu Sun, Linqing Zhao, Jing Yuan

Pharmaceuticals · 16.03.2026 · 19 (3) · 488

DOI: 10.3390/ph19030488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 16.03.2026. Verfasst von Chao Yan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, Capital Center for Children Health, Capital Medical University, Capital Institute of Pediatrics, Beijing 100020, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, the National Key Research and Development Program of China, Beijing Hospitals Authority's Ascent Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The aim of this study was to clarify the antimicrobial susceptibility and distribution characteristics of Mycoplasma pneumoniae (M. pneumoniae, MP) collected from children in Beijing, China, from 2017 to 2025. Methods: A total of 197 MP isolates were analyzed. Mutations in macrolide-resistant loci of MP strains were detected via real-time fluorescent quantitative polymerase chain reactions. We used the broth microdilution method to determine the minimum inhibitory concentrations (MICs) of erythromycin, azithromycin, tetracycline, levofloxacin, and moxifloxacin against these isolates. The distribution characteristics of MIC values were further analyzed according to the isolates’ collection year, epidemic phase (low epidemic phase, epidemic initiation phase, ultra-low epidemic phase, outbreak phase, and epidemic recovery phase), and the corresponding patient age group (

Schlagwörter

Stichwörter der Autor:innen

Mycoplasma pneumoniaeMycoplasma pneumoniae pneumoniachildrenmacrolide resistanceminimum inhibitory concentrations

Autor:innen und Institutionen

  • Department of Bacteriology, Capital Center for Children Health, Capital Medical University, Capital Institute of Pediatrics, Beijing 100020, China.
  • Capital Institute of Pediatrics-Peking University Teaching Hospital, Beijing 100020, China.
  • Capital Institute of Pediatrics, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100020, China.
  • Department of Virology, Capital Center for Children Health, Capital Medical University, Capital Institute of Pediatrics, Beijing 100020, China.

Förderung

  • Beijing Natural Science Foundation
  • the National Key Research and Development Program of China
  • Beijing Hospitals Authority's Ascent Plan
  • Beijing High-Level Public Health Technical Talent Project
  • Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes
  • National Key Research and Development Program of China
  • Beijing Hospitals Authority’s Ascent Plan

Zitieren

APA

Yan, C., Chen, Y., Su, A., Liu, X., Jia, X., Ren, X., Zhao, H., Feng, Y., Cui, J., Sun, Y., Zhao, L., & Yuan, J. (2026). Antimicrobial Susceptibility and Distribution Characteristics of Mycoplasma pneumoniae Isolates in Beijing, China, from 2017 to 2025. Pharmaceuticals, 19(3), 488. https://doi.org/10.3390/ph19030488

Vancouver

Yan C, Chen Y, Su A, Liu X, Jia X, Ren X, et al. Antimicrobial Susceptibility and Distribution Characteristics of Mycoplasma pneumoniae Isolates in Beijing, China, from 2017 to 2025. Pharmaceuticals. 2026;19(3):488. doi:10.3390/ph19030488

BibTeX
@article{Yan2026,
  author = {Yan, Chao and Chen, Yujie and Su, An and Liu, Xuanfeng and Jia, Xinyu and Ren, Xue and Zhao, Hanqing and Feng, Yanling and Cui, Jinghua and Sun, Yu and Zhao, Linqing and Yuan, Jing},
  title = {Antimicrobial Susceptibility and Distribution Characteristics of Mycoplasma pneumoniae Isolates in Beijing, China, from 2017 to 2025},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {3},
  pages = {488},
  doi = {10.3390/ph19030488}
}
Kostenlos starten →